Choline theophyllinate
Pharmaceutical drug
- R03DA02 (WHO)
- (2-Hydroxyethyl)trimethylazanium; 1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-ide
- 4499-40-5 Y
- 656652
- DB01303
- 25044543
- 571001
- 3K045XR58X
- D02017
- ChEMBL1200434
- DTXSID20894867
- Interactive image
- Cn1c(c-2ncnc2n(c1=O)C)[O-].C[N+](C)(C)CCO
InChI
- InChI=1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3,12H,1-2H3;7H,4-5H2,1-3H3/q;+1/p-1
- Key:SOELXOBIIIBLRJ-UHFFFAOYSA-M
Choline theophyllinate (INN), also known as oxtriphylline, is a cough medicine derived from xanthine that acts as a bronchodilator to open up airways in the lung. Chemically, it is a salt of choline and theophylline. It classifies as an expectorant.[citation needed] The drug is available under the brand names Choledyl and Choledyl SA, among others.[1]
References
- ^ Drugs.com: Choledyl (oxtriphylline) medical facts
- v
- t
- e
Short-acting β2 agonists | |
---|---|
Long-acting β2 agonists |
|
Ultra-long-acting β2 agonists | |
Other |
muscarinic antagonist
- Acefylline
- Ambuphylline
- Aminophylline
- Bamifylline
- Choline theophyllinate
- Doxofylline
- Enprofylline
- Etamiphylline
- Proxyphylline
- Theophylline
Leukotriene antagonists | |
---|---|
Arachidonate 5-lipoxygenase inhibitors | |
Thromboxane receptor antagonists | |
Non-xanthine PDE4 inhibitors |
- Aclidinium bromide/formoterol
- Beclometasone/formoterol
- Beclometasone/formoterol/glycopyrronium bromide
- Budesonide/formoterol
- Budesonide/glycopyrronium bromide/formoterol
- Fluticasone furoate/umeclidinium bromide/vilanterol
- Fluticasone furoate/vilanterol
- Fluticasone propionate/salmeterol
- Glycopyrronium bromide/formoterol
- Indacaterol/glycopyrronium bromide
- Indacaterol/glycopyrronium bromide/mometasone
- Indacaterol/mometasone
- Ipratropium bromide/salbutamol
- Mometasone/formoterol
- Salbutamol (albuterol)/budesonide
- Theophylline/ephedrine
- Theophylline/ephedrine/hydroxyzine
- Theophylline/ephedrine/phenobarbital
- Umeclidinium bromide/vilanterol
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e